Cargando…

1430. The Hidden Costs of Vancomycin Use During the Treatment of Staphylococcus aureus Bacteremia Concurrent with Acute Hematogenous Osteomyelitis

BACKGROUND: Current guidelines recommend the use of parenteral vancomycin for children with acute hematogenous osteomyelitis and concurrent Staphylococcus aureus bacteremia (SAB) due to Methicillin-Resistant Staphylococcus aureus (MRSA), despite vancomycin’s slow bactericidal activity. This study ex...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ashley. Copley, Lawson, Sanchez, Maria J, Sue, Paul K, Lindsay, Eduardo A, Patel, Karisma, Tareen, Naureen G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6808846/ http://dx.doi.org/10.1093/ofid/ofz360.1294

Ejemplares similares

1427. Treatment of Children with Acute Hematogenous Osteomyelitis and Staphylococcus aureus Bacteremia: Impact of Severity of Illness on Antimicrobial Therapy
por: Copley, Lawson Ashley, et al.
Publicado: (2019)

The impact of Staphylococcus aureus genomic variation on clinical phenotype of children with acute hematogenous osteomyelitis
por: Collins, Angela, et al.
Publicado: (2018)

Gene Expression Analysis of Children with Acute Hematogenous Osteomyelitis Caused by Methicillin-Resistant Staphylococcus aureus: Correlation with Clinical Severity of Illness
por: Gaviria-Agudelo, Claudia, et al.
Publicado: (2014)

Genomic Heterogeneity of Methicillin Resistant Staphylococcus aureus Associated with Variation in Severity of Illness among Children with Acute Hematogenous Osteomyelitis
por: Gaviria-Agudelo, Claudia, et al.
Publicado: (2015)

Staphylococcus aureus isolates from children with clinically differentiated osteomyelitis exhibit distinct transcriptomic signatures
por: Hachem, Ahmad A., et al.
Publicado: (2023)

189. Risk Factors and Outcomes of Hematogenous Vertebral Osteomyelitis in Patients with staphylococcus Aureus Bacteremia: Results from a 20-year Prospective Cohort
por: Dagher, Michael M, et al.
Publicado: (2020)

Staphylococcus aureus Regulator Sigma B is Important to Develop Chronic Infections in Hematogenous Murine Osteomyelitis Model
por: Tuchscherr, Lorena, et al.
Publicado: (2017)

Subacute hematogenous osteomyelitis of the fibula
por: Jlalia, Zied, et al.
Publicado: (2020)

P199: Clinical characteristics and therapeutic outcomes of hematogenous vertebral osteomyelitis caused by methicillin-resistant Staphylococcus aureus
por: Lee, MS, et al.
Publicado: (2013)

High Vancomycin MIC and Complicated Methicillin-Susceptible Staphylococcus aureus Bacteremia
por: Aguado, Jose Maria, et al.
Publicado: (2011)

The role of Staphylococcus aureus lipoproteins in hematogenous septic arthritis
por: Mohammad, Majd, et al.
Publicado: (2020)

Treatment of Methicillin-resistant Staphylococcus aureus experimental Osteomyelitis with bone-targeted Vancomycin
por: Karau, Melissa J, et al.
Publicado: (2013)

136. Factors Associated with Reduced Vancomycin Susceptibility in Pediatric Staphylococcus aureus Bacteremia
por: Ericson, Jessica E, et al.
Publicado: (2019)

Methicillin-resistant Staphylococcus aureus bacteremia with elevated vancomycin minimum inhibitory concentrations
por: Mills, Alexandra G., et al.
Publicado: (2023)

Pediatric pharmaceutical care with anti-infective medication in a patient with acute hematogenous osteomyelitis caused by methicillin-resistant Staphylococcus aureus
por: Lv, Chanmei, et al.
Publicado: (2020)

Hemipelvic osteomyelitis in a hemodialysis patient associated with methicillin-resistant Staphylococcus aureus bacteremia
por: Patzkowski, Jeanne C, et al.
Publicado: (2008)

A Case of Primary Sternomanubrial Osteomyelitis With Oxacillin-Resistant Staphylococcus aureus (ORSA) Bacteremia
por: Assaad, Marc, et al.
Publicado: (2022)

Staphylococcus aureus with reduced susceptibility to vancomycin isolated from a patient with fatal bacteremia.
por: Rotun, S S, et al.
Publicado: (1999)

Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia
por: Schweizer, Marin L, et al.
Publicado: (2011)

Clinical Significance of Varying Degrees of Vancomycin Susceptilibity in Methicillin-Resistant Staphylococcus aureus Bacteremia
por: Schwaber, Mitchell J., et al.
Publicado: (2003)

Effectiveness of Daptomycin in Patients with Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia Despite Vancomycin
por: Kale-Pradhan, Pramodini, et al.
Publicado: (2017)

The impact of vancomycin susceptibility on treatment outcomes among patients with methicillin resistant Staphylococcus aureus bacteremia
por: Honda, Hitoshi, et al.
Publicado: (2011)

Vancomycin monotherapy vs. combination therapy for the treatment of persistent methicillin-resistant Staphylococcus aureus bacteremia
por: Seah, Jonathan, et al.
Publicado: (2013)

1062. Daptomycin/Ceftaroline in Combination vs. Vancomycin for the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
por: Fox, Matthew, et al.
Publicado: (2018)

Effects of pharmacist intervention in Vancomycin treatment for patients with bacteremia due to Methicillin-resistant Staphylococcus aureus
por: Komoto, Atsushi, et al.
Publicado: (2018)

187. Vancomycin Plus Ceftaroline Salvage Therapy for Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia
por: Kufel, Wesley D, et al.
Publicado: (2021)

1033. Unexpected Allies: Vancomycin and Cefazolin Combination Therapy in Methicillin-Resistant Staphylococcus aureus Bacteremia
por: Caniff, Kaylee E, et al.
Publicado: (2023)

Hematogenous Long Bone Osteomyelitis by Prevotella (Bacteroides) Melaninogenicus
por: Karabinas, Panagiotis K, et al.
Publicado: (2010)

1366. Microbiology of Acute Hematogenous Osteomyelitis in Hospitalized Children
por: Hu, Nina, et al.
Publicado: (2020)

Acute hematogenous osteomyelitis of the talus: a case report
por: Dammak, Nabil, et al.
Publicado: (2020)

Acute Hematogenous Osteomyelitis in Children: Clinical Presentation and Management
por: McNeil, J Chase
Publicado: (2020)

Intracardiac Abscess and Pacemaker Lead Infection Secondary to Hematogenous Dissemination of Methicillin-Sensitive Staphylococcus Aureus from a Prior Diabetic Foot Ulcer and Osteomyelitis
por: Pfirman, Kristopher S., et al.
Publicado: (2018)

Vancomycin Resistance in Staphylococcus aureus 
por: McGuinness, Will A., et al.
Publicado: (2017)

Staphylococcus aureus Bacteremia, Australia
por: Collignon, Peter, et al.
Publicado: (2005)

Staphylococcus aureus Bacteremia, Europe
por: Tiemersma, Edine W., et al.
Publicado: (2005)

Clinical, Microbiological, and Genetic Characteristics of Heteroresistant Vancomycin-Intermediate Staphylococcus aureus Bacteremia in a Teaching Hospital
por: Di Gregorio, Sabrina, et al.
Publicado: (2015)

Staphylococcus aureus bacteremia in a secondary level Spanish hospital: clinical implications of high vancomycin MIC
por: Abelenda Alonso, Gabriela, et al.
Publicado: (2018)

Septic Thrombophlebitis with Persistent Methicillin-Resistant Staphylococcus Aureus Bacteremia and de Novo Resistance to Vancomycin and Daptomycin
por: Koton, Yael, et al.
Publicado: (2017)

Evolution of Multi-Resistance to Vancomycin, Daptomycin, and Linezolid in Methicillin-Resistant Staphylococcus aureus Causing Persistent Bacteremia
por: Chen, Chih-Jung, et al.
Publicado: (2020)

276. Comparison of Ceftaroline in Combination with Either Vancomycin or Daptomycin for the Treatment of Methicillin-resistant Staphylococcus aureus Bacteremia
por: Welch, Stephanie N, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_r0lv0tmrtn3q9em8msdulfsq34